| Element List | Explanation |
|---|---|
| Introduction | The Board of Directors of Al-Razi Medical Company is pleased to invite the honorable shareholders to participate and vote in the second extraordinary general assembly meeting (first meeting), which is scheduled to be held, God willing, at 6:30 PM on Sunday 11/20/1446 AH, corresponding to 05/18/2025 AD, at the company’s headquarters in Al-Badayea Governorate in Al-Qassim Region, using modern technology. |
| City and Location of the General Assembly's Meeting | The company's headquarters is located in Al-Badayea Governorate, Al-Qassim Region, using modern technology. |
| Hyperlink of the Meeting Location | Click Here |
| Date of the General Assembly's Meeting | 2025-05-18 Corresponding to 1446-11-20 |
| Time of the General Assembly’s Meeting | 18:30 |
| Methodology of Convening the General Assembly’s Meeting | Via modern technology means |
| Attendance Eligibility, Registration Eligibility, and Voting End | Shareholders who are registered in the issuers shareholders record at the Depositary Center by the end of the trade session prior to the general assembly meeting and in accordance with the laws and regulations. The shareholder has the right to delegate whomever other than the board of directors. The right to register a name to attend the general assembly meeting ends at the time of convening the general assembly meeting. The attendees right to vote on the items of the assembly’s agenda ends upon the end of screening the votes by the Screening Committee. |
| Quorum for Convening the General Assembly's Meeting | An extraordinary general meeting shall be valid if attended by shareholders representing at least half of the company's shares with voting rights. |
| General Assembly Meeting Agenda | 1. Review and discuss the Board of Directors' report for the fiscal year ending December 31, 2024. 2. Review and discuss the financial statements for the fiscal year ending December 31, 2024. 3. Vote on the auditor's report for the fiscal year ending December 31, 2024, after discussing it. 4. Vote on the appointment of the company's auditor from among the candidates, based on the Audit Committee's recommendation, to examine, review, and audit the semi-annual and annual financial statements for the fiscal year 2025, and determine their remuneration. 5. Vote on absolving the members of the Board of Directors from liability for the fiscal year ending December 31, 2024. 6. Voting on the Board of Directors' decision to appoint Mr. Abdulmajeed bin Abdulrahman Al-Arini as an independent member of the Board of Directors, effective from the date of his appointment on January 23, 2025, to complete the Board's term until the end of the current term on September 8, 2026, succeeding former member Abdulaziz bin Abdullah Al-Oud, an independent member. (CV attached). 7. Voting on transferring the balance of the company's statutory reserve, which amounted to (561,323) five hundred and sixty-one thousand three hundred and twenty-three Saudi riyals, according to the annual financial statements ending December 31, 2024, to the retained earnings balance. |
| Proxy Form | Proxy Form |
| The shareholder right in discussing the assembly agenda topics, asking questions, and exercising the voting right | Shareholders have the right to discuss the topics included on the General Assembly's agenda and to ask questions. Registration and voting in Tadawulaty services are available and free to all shareholders using the following link: www.tadawulaty.com.sa |
| Details of the electronic voting on the Assembly’s agenda | Shareholders registered on the Tadawulaty e-Services website will be able to vote remotely on the general assembly's agenda items through the "electronic voting" service, which will begin at 1:00 AM on Thursday, May 15, 2025, corresponding to November 17, 1446 AH, and continue until the end of the general assembly meeting. Registration and voting on Tadawulaty Services will be available and free to all shareholders using the following link: www.tadawulaty.com.sa |
| Method of Communication in Case of Any Enquiries | If you have any questions about the assembly’s agenda, please contact the Shareholder Relations Department via email at info@alraziksa.com. |
| Attached Documents | Attached Documents Attached Documents Attached Documents Attached Documents |
